John L. Mattana

New York Life Investment Management LLC (NYLIM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 and is a wholly-owned subsidiary of New York Life Investment Management Holdings LLC, owned by New York Life Insurance Co. NYLIM provides a broad array of investment advisory services to third-party institutional clients, affiliated insurance companies, investment companies, other pooled investment vehicles, individuals and wrap fee programs sponsored by unaffiliated entities.

Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.

IDEV Technologies, Inc. develops medical devices for endovascular uses. Its products include interventional cardiology, interventional radiology and vascular surgery. The company was founded by Sheldon J. Jeffery in 1999 and is headquartered in Webster, TX.

New York Life Insurance & Annuity Corp. provides investment advice for Insurance Company Portfolio. The company is headquartered in New York, NY.

Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Groton School is a college preparatory, coeducational boarding school. Its curriculum aims to foster the development of critical and discipline thinking, precise communication and scientific analysis, creative problem-solving, careful and logical thinking, and empathetic understanding of the social, scientific input of Western and non-Western civilization. Groton School was founded in 1884. It is headquartered in Groton, MA.

Cameron Health, Inc. develops medical devices for patients and medical professionals. It has developed a totally subcutaneous implantable defibrillator (S-ICD) system that remedies many of the issues associated with traditional implantable cardioverter defibrillators. The company was founded on August 21, 2000 and is headquartered in San Clemente, CA.

PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas.

San Francisco Opera Association owns and operates opera theater. It offers an array of training programs and performance opportunities for young artists under the support of the San Francisco Opera Center and the Merola Opera Program. The company was founded by Gaetano Merola in 1923 and is headquartered in San Francisco, CA.

Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA.

The Rubin Museum of Art operates an art museum. The private company is based in New York, NY.

Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA.

SB2, Inc. is a law firm based in Princeton, WI that specializes in providing support, representation, and services related to Medicare/Medicaid eligibility and reimbursement. The private company offers policies and procedures to promote consistent and effective methods of addressing eligibility issues at the facility level. The company also challenges adverse reimbursement decisions made by state agencies, MCOs, and Medicare contractors. SB2's team of lawyers helps clients make the most of their businesses by providing easier and more efficient access to Medicaid and Medicare, regardless of their size.

Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC.

Sinovation Ventures Co Ltd (Sinovation Ventures) is a venture capital firm founded in 2009 by Dr. Kai-Fu Lee. The firm is headquartered in Beijing, China.

Part of Baxter International, Inc., Baxter Healthcare Ltd. is a company based in Newbury, UK. Baxter Healthcare Ltd. helps maximize safety, streamline processes, and build cost efficiency throughout the hospital, from the pharmacy to the bedside. The British company was founded in 1948. José E. Almeida has been the CEO of the company since 2016.

New York Life Insurance Co. (Investment Portfolio) (NYLIC-IP) is the investment portfolio division of New York Life Insurance Co., a mutual life insurance company headquartered in New York City. Founded in 1845, the firm provides insurance, investment and retirement solutions. NYLIC-IP manages the insurance investment portfolio.

NCL Technology Ventures Ltd. (NCL Technology Ventures) is an venture capital firm founded in 2010 by Jerry Biggs. The firm is headquartered in London, United Kingdom.

CU-BX Automotive Technologies Ltd. develops remote, contact-free driving monitoring sensors technology which enables users to detect deterioration in medical conditions. It monitors remotely biometric parameters such as blood pressure, cardiographs, muscle activities, heart and lung sounds, and biochemical screens. The company was founded by Asher Polani, Evgeny Beiderman, Amit Klir, Javier Garcia, and Zeev Zalevsky on March 8, 2015 and is headquartered in Tel Aviv, Israel.

Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA.

Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009.

10032506 Canada, Inc. is a Canadian Montreal-based company founded in 2016 by Marc Reeves, Etienne de Villers-Sidani, and Yves Desgagné. The company has developed a patented mobile technology for capturing digital biomarkers of neurodegenerative and mental diseases such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, and related disorders, frontotemporal dementia, and related disorders, as well as cancer-related cognitive disorders ("chemo brain"). The technology is embodied in an ISO/HIPAA-compliant system consisting of an intuitive iPad Pro application connected to a cloud-based artificial intelligence infrastructure. The application consists of a series of simple visual tasks that are completed in a matter of minutes, and the users' eye movements and gaze patterns are extracted and recorded in the form of hundreds of measurements called eye movement biomarkers (EMB) and gaze mapping biomarkers (GMB). The company's mission is to become the digital leader in mobile applications that can easily extract EMBs and GMBs through its AI-powered technology to better meet the needs of the healthcare system. Etienne de Villers-Sidani has been the CEO since 2016.